Aléssio M L, Léger C L, Rasolonjanahary R, Wandscheer D E, Clauser H, Enjalbert A, Kordon C
INSERM U-159, Unité de Neuroendocrinologie, Centre Paul-Broca, Paris, France.
Neuroendocrinology. 1994 Oct;60(4):400-9. doi: 10.1159/000126774.
Young rats were fed on an essential fatty acid (EFA)-deprived diet for 6 weeks after weaning. Their pituitary was removed and adenohypophyseal cells dispersed and maintained in culture. Membrane lipids were analyzed and basal and stimulated levels of hormone secretion were measured after 4-day incubation in a culture medium containing or not 160 microM arachidonic acid 20:4n-6 (AA) in order to obtain EFA-deficient or EFA-restored pituitary cells, respectively. In EFA-deficient cells membrane phosphoglycerides (PGL) were depleted in AA and adrenic acid 22:4n-6; the deficit was overcome by incubation in the presence of AA. Depletion diversely affected PGL classes. AA was highly depleted in choline phosphoglycerides (ChoPG), only moderately depleted in serine and ethanolamine phosphoglycerides (SerPG and EtnPG) and not depleted at all in inositol phosphoglycerides, suggesting preferential preservation of AA in that class of PGL. Restoration of AA by addition of the fatty acid to the culture medium was complete for ChoPG and EtnPG and only partial for SerPG. Depressed levels of AA and adrenic acid in PGL were compensated for by a concomitant increase in 20:3n-9 and 22:3n-9. Growth hormone and prolactin (PRL) secretion was assessed by radioimmunoassay and possible effects of a membrane AA deficit on hormone regulation were tested in cells challenged by either growth hormone-releasing hormone, thyrotropin-releasing hormone, angiotensin II (AII), vasoactive intestinal peptide (VIP) or dopamine. Neither basal nor stimulated growth hormone secretion was different from controls in EFA-deficient cells. PRL modulation by VIP or dopamine was not affected either in EFA-deficient cells. In contrast, the capacity of AII, but not of thyrotropin-releasing hormone, to release PRL was markedly decreased in EFA-deprived cells. It was restored by addition of AA to the incubation medium. Parallel depression of AII-induced inositol phosphates and cAMP accumulation was also observed after EFA deficiency. When tested on membranes, the paradoxical inhibition of adenylate cyclase by AII documented by previous observations was reinforced in EFA-deficient membranes. In contrast, binding of AII was not affected by EFA deficiency. It is concluded that under our experimental conditions EFA deficiency affects selectively coupling of the AII receptor to its effectors without alteration of binding. The effect could involve changes in receptor interactions with coupling proteins.
幼鼠断奶后用缺乏必需脂肪酸(EFA)的饲料喂养6周。切除其垂体,将腺垂体细胞分散并进行培养。分析膜脂,并在含有或不含160微摩尔花生四烯酸20:4n-6(AA)的培养基中孵育4天后,分别测定激素分泌的基础水平和刺激水平,以分别获得EFA缺乏或EFA恢复的垂体细胞。在EFA缺乏的细胞中,膜磷酸甘油酯(PGL)中的AA和肾上腺酸22:4n-6减少;在AA存在下孵育可克服这种缺乏。这种缺乏对PGL类别有不同影响。AA在胆碱磷酸甘油酯(ChoPG)中高度减少,在丝氨酸和乙醇胺磷酸甘油酯(SerPG和EtnPG)中仅中度减少,而在肌醇磷酸甘油酯中根本没有减少,这表明在这类PGL中AA优先得到保留。通过向培养基中添加脂肪酸来恢复AA,对于ChoPG和EtnPG是完全的,而对于SerPG只是部分的。PGL中AA和肾上腺酸水平的降低伴随着20:3n-9和22:3n-9的相应增加而得到补偿。通过放射免疫测定法评估生长激素和催乳素(PRL)的分泌,并在受到生长激素释放激素、促甲状腺激素释放激素、血管紧张素II(AII)、血管活性肠肽(VIP)或多巴胺刺激的细胞中测试膜AA缺乏对激素调节的可能影响。在EFA缺乏的细胞中,基础生长激素分泌和刺激后的生长激素分泌与对照均无差异。EFA缺乏的细胞中VIP或多巴胺对PRL的调节也未受影响。相反,在EFA缺乏的细胞中,AII释放PRL的能力显著降低,但促甲状腺激素释放激素没有这种情况。通过向孵育培养基中添加AA可恢复这种能力。EFA缺乏后还观察到AII诱导的肌醇磷酸和cAMP积累的平行降低。当在膜上进行测试时,先前观察到的AII对腺苷酸环化酶的矛盾抑制在EFA缺乏的膜中得到增强。相反,EFA缺乏对AII的结合没有影响。得出的结论是,在我们的实验条件下,EFA缺乏选择性地影响AII受体与其效应器的偶联,而不改变结合。这种效应可能涉及受体与偶联蛋白相互作用的变化。